dr. brander on the safety and efficacy of ibrutinib/venetoclax in cll
Published 5 years ago • 559 plays • Length 2:12Download video MP4
Download video MP3
Similar videos
-
12:05
venetoclax combinations, safety and efficacy
-
1:15
dr. lampson on safety and efficacy of acalabrutinib, venetoclax, and obinutuzumab in cll
-
2:39
the safety and efficacy of ibrutinib for the treatment of cll
-
4:07
management of cll progression after ibrutinib
-
1:31
dr. smith on the rationale behind the fixed duration trial for ibrutinib/venetoclax in cll
-
1:05
dr. smith on using venetoclax versus ibrutinib in cll
-
1:13
dr. jones on the safety of venetoclax in cll
-
7:34
safety and efficacy of cll treatments
-
1:08
dr. tam on the toxicity of ibrutinib plus venetoclax in mcl
-
2:04
dr. chavez on ongoing efficacy and challenges with ibrutinib in cll
-
2:16
dr. jones on the efficacy of venetoclax in relapsed/refractory cll
-
3:33
investigating the safety and efficacy of re-treating cll patients with venetoclax-based regimens
-
3:01
ibrutinib venetoclax for cll
-
0:47
dr. davids on the potential utility of frontline ibrutinib/umbralisib in mcl and cll
-
9:15
obinutuzumab venetoclax for frontline cll
-
1:36
improve study update: safety and efficacy of venetoclax retreatment in r/r cll
-
2:02
dr. jain on the combination of venetoclax and ibrutinib in cll
-
1:38
dr. brander on targeted agents in cll
-
1:27
dr. rule on the combination of venetoclax and ibrutinib in mcl